Accrued and other current liabilities consist of the following:
March 31,2025
December 31,2024
Manufacturing and other research and development services
$
2,057
3,491
Clinical trial research and development services
2,466
—
General and administrative services
407
342
Compensation expense
3,323
8,315
Other
50
40
8,303
12,188
Accrued expenses and other current liabilities.
No definition available.